Real-time enrollment status for this advanced malignant solid neoplasm clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 2:48 AM UTC
| NCT Number | NCT04678648 |
| Recruiting Status | Recruiting |
| Condition | Advanced Malignant Solid Neoplasm |
| Phase | PHASE1 |
| Target Enrollment | 134 participants |
| Active Locations | 3 sites in the US |
| Sponsor | RasCal Therapeutics, Inc. |
| Last Updated on CT.gov | June 23, 2026 (Jun 23, 2026) |
As of August 28, 2026: Clinical trial NCT04678648 is currently recruiting participants. This phase1 study for advanced malignant solid neoplasm is actively seeking new participants at 3 locations across the United States. The study is sponsored by RasCal Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04678648 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04678648 was last updated Jun 23, 2026 (June 23, 2026). HelloStudys verifies this status automatically.